Substituted triazolone, compound
PK139957AUndetermined Publication Date: 2009-01-30JANSSEN PHARMA NV
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200501235
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2009-01-30
Abstract
The present invention concerns substituted triazolone compound according to the general Formula (I) wherein the variables are defined in specification having selective α2c-adrenoceptor antagonist activity. It further relates to their preparation, compositions comprising them and their use as a medicine. The compound according to the invention is usefull for the prevention and / or treatment of central nervous system disorders, mood disorders, anxiety disorders, stress-related disorders associated with depression and / or anxiety, cognitive disorders, personality disorders, schizoaffective disorders, Parkinson's disease, dementia of the Alzheimer's type, chronic pain conditions, neurodegenerative diseases, addiction disorders, mood disorders and sexual dysfunction.
Need to check novelty before this filing date? Find Prior Art
